Bibliographic Info
GuidelineGuidelines for the prevention, care and treatment of persons with chronic hepatitis B infection
Year of Publication2015
Issuing InstitutionWorld Health Organization
Recommendation
Status
Maintained
Recommended against
Strong
Certainty of evidence
Moderate
FIRST-LINE ANTIVIRAL THERAPIES FOR CHRONIC HEPATITIS B. Nucleos(t)ide analogues (NAs) s with a low barrier to resistance (lamivudine, adefovir or telbivudine) can lead to drug resistance and are not recommended
Also Featured In
This recommendation also appears in the following guidelines:
Guideline
Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection.
Year2024
InstitutionWHO